Young-ho Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 30, 2023
Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents.
Journal: European journal of medicinal chemistry
Published: August 02, 2022
Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.
Journal: European journal of medicinal chemistry
Published: July 19, 2021
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.
Journal: Journal of medicinal chemistry
Published: November 09, 2019
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.
Journal: Journal of medicinal chemistry
Published: August 15, 2019
Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: March 27, 2018
Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region.
Journal: Bioorganic & medicinal chemistry
Published: January 02, 2018
Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system.
Journal: PloS one
Published: March 16, 2017
Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.
Journal: Journal of medicinal chemistry
Published: February 25, 2017
6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE).
Journal: Bioorganic & medicinal chemistry
Published: April 06, 2015
Synthesis and structure-activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry letters
Published: August 13, 2012
Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors.
Journal: Journal of medicinal chemistry
Published: June 30, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026